163 related articles for article (PubMed ID: 37658846)
21. CheckMate 743: A Glimmer of Hope for Malignant Pleural Mesothelioma.
Uprety D
Clin Lung Cancer; 2021 Mar; 22(2):71-73. PubMed ID: 33358660
[No Abstract] [Full Text] [Related]
22. Localised malignant pleural mesothelioma: a separate clinical entity requiring aggressive local surgery.
Nakas A; Martin-Ucar AE; Edwards JG; Waller DA
Eur J Cardiothorac Surg; 2008 Feb; 33(2):303-6. PubMed ID: 18155556
[TBL] [Abstract][Full Text] [Related]
23. Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP.
Dubois F; Bazille C; Levallet J; Maille E; Brosseau S; Madelaine J; Bergot E; Zalcman G; Levallet G
Target Oncol; 2022 Jul; 17(4):407-431. PubMed ID: 35906513
[TBL] [Abstract][Full Text] [Related]
24. FDA Approval Summary: Nivolumab in Combination with Ipilimumab for the Treatment of Unresectable Malignant Pleural Mesothelioma.
Nakajima EC; Vellanki PJ; Larkins E; Chatterjee S; Mishra-Kalyani PS; Bi Y; Qosa H; Liu J; Zhao H; Biable M; Hotaki LT; Shen YL; Pazdur R; Beaver JA; Singh H; Donoghue M
Clin Cancer Res; 2022 Feb; 28(3):446-451. PubMed ID: 34462287
[TBL] [Abstract][Full Text] [Related]
25. Nivolumab plus ipilimumab in malignant pleural mesothelioma.
Travert C; Tomasini P; Greillier L
Expert Rev Anticancer Ther; 2022 Aug; 22(8):815-822. PubMed ID: 35835722
[TBL] [Abstract][Full Text] [Related]
26. [Early malignant pleural mesothelioma; report of a case].
Eba S; Karube Y; Minowa M; Chida M; Matsumura Y; Matsuura Y; Odajima H; Tsuda T
Kyobu Geka; 2009 Jul; 62(7):598-601. PubMed ID: 19588835
[TBL] [Abstract][Full Text] [Related]
27. [Malignant pleural mesothelioma: diagnosis, therapy and prognosis].
Geroulanos S; Lampe P; Häfner F; Buchmann P; Largiadèr F
Schweiz Rundsch Med Prax; 1990 Mar; 79(12):361-7. PubMed ID: 1690909
[TBL] [Abstract][Full Text] [Related]
28. Soluble Mesothelin-Related Peptides to Monitor Recurrence After Resection of Pleural Mesothelioma.
Burt BM; Lee HS; Lenge De Rosen V; Hamaji M; Groth SS; Wheeler TM; Sugarbaker DJ
Ann Thorac Surg; 2017 Nov; 104(5):1679-1687. PubMed ID: 28964420
[TBL] [Abstract][Full Text] [Related]
29. Treatment patterns and outcomes of patients with advanced malignant pleural mesothelioma in a community practice setting.
Waterhouse DM; Nwokeji ED; Boyd M; Penrod JR; Espirito JL; Robert NJ; Daumont MJ
Future Oncol; 2021 Jul; 17(19):2439-2448. PubMed ID: 33769073
[TBL] [Abstract][Full Text] [Related]
30. Immune cells in mesothelioma microenvironment simplistic marker of response to nivolumab plus ipilimumab?
Disselhorst MJ; Lubeck Y; van der Noort V; Quispel-Janssen J; Seignette IM; Sanders J; Peters D; Hooijberg E; Baas P
Lung Cancer; 2022 Nov; 173():49-52. PubMed ID: 36122471
[TBL] [Abstract][Full Text] [Related]
31. Dynamics and survival associations of T cell receptor clusters in patients with pleural mesothelioma treated with immunotherapy.
Desai AP; Kosari F; Disselhorst M; Yin J; Agahi A; Peikert T; Udell J; Johnson SH; Smadbeck J; Murphy S; Karagouga G; McCune A; Schaefer-Klein J; Borad MJ; Cheville J; Vasmatzis G; Baas P; Mansfield A
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37279993
[TBL] [Abstract][Full Text] [Related]
32. Imaging of Malignant Pleural, Pericardial, and Peritoneal Mesothelioma.
Strange CD; Marom EM; Ahuja J; Shroff GS; Gladish GW; Carter BW; Truong MT
Adv Anat Pathol; 2023 Jul; 30(4):280-291. PubMed ID: 36395181
[TBL] [Abstract][Full Text] [Related]
33. Localized pleural malignant mesothelioma.
Erkiliç S; Sari I; Tunçözgür B
Pathol Int; 2001 Oct; 51(10):812-5. PubMed ID: 11881736
[TBL] [Abstract][Full Text] [Related]
34. NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma.
Haakensen VD; Nowak AK; Ellingsen EB; Farooqi SJ; Bjaanæs MM; Horndalsveen H; Mcculloch T; Grundberg O; Cedres SM; Helland Å
J Transl Med; 2021 May; 19(1):232. PubMed ID: 34059094
[TBL] [Abstract][Full Text] [Related]
35. Computed tomography in the evaluation of malignant pleural mesothelioma-Association of tumor size to a sarcomatoid histology, a more advanced TNM stage and poor survival.
Paajanen J; Laaksonen S; Ilonen I; Wolff H; Husgafvel-Pursiainen K; Kuosma E; Ollila H; Myllärniemi M; Vehmas T
Lung Cancer; 2018 Feb; 116():73-79. PubMed ID: 29413055
[TBL] [Abstract][Full Text] [Related]
36. Solitary cerebellar metastasis of malignant pleural mesothelioma: case report.
Winfree CJ; Mack WJ; Sisti MB
Surg Neurol; 2004 Feb; 61(2):174-8; discussion 178-9. PubMed ID: 14751636
[TBL] [Abstract][Full Text] [Related]
37. The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma.
Stewart DJ; Martin-Ucar A; Pilling JE; Edwards JG; O'Byrne KJ; Waller DA
Ann Thorac Surg; 2004 Jul; 78(1):245-52. PubMed ID: 15223437
[TBL] [Abstract][Full Text] [Related]
38. Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.
Zalcman G; Mazieres J; Margery J; Greillier L; Audigier-Valette C; Moro-Sibilot D; Molinier O; Corre R; Monnet I; Gounant V; Rivière F; Janicot H; Gervais R; Locher C; Milleron B; Tran Q; Lebitasy MP; Morin F; Creveuil C; Parienti JJ; Scherpereel A;
Lancet; 2016 Apr; 387(10026):1405-1414. PubMed ID: 26719230
[TBL] [Abstract][Full Text] [Related]
39. Malignant pleural mesothelioma in a 14-year-old boy with right aortic arch.
Hosaka M; Ohde Y; Nakagawa K; Okumura T; Kameya T; Kondo H
Jpn J Thorac Cardiovasc Surg; 2006 Oct; 54(10):458-61. PubMed ID: 17087330
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of nivolumab with ipilimumab for recurrent malignant pleural mesothelioma after primary surgical intervention.
Nakamura A; Hashimoto M; Kondo N; Matsumoto S; Kuroda A; Minami T; Kitajima K; Kuribayashi K; Kijima T; Hasegawa S
Int J Clin Oncol; 2023 Mar; 28(3):409-415. PubMed ID: 36609928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
